Compare SRRK & ATR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SRRK | ATR |
|---|---|---|
| Founded | 2012 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Plastic Products |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.8B | 7.7B |
| IPO Year | 2018 | 1995 |
| Metric | SRRK | ATR |
|---|---|---|
| Price | $47.76 | $132.42 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 4 |
| Target Price | $56.17 | ★ $170.25 |
| AVG Volume (30 Days) | ★ 1.2M | 387.8K |
| Earning Date | 05-07-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 1.56% |
| EPS Growth | N/A | ★ 6.51 |
| EPS | N/A | ★ 1.12 |
| Revenue | N/A | ★ $3,777,181,000.00 |
| Revenue This Year | N/A | $5.18 |
| Revenue Next Year | $534.24 | $4.98 |
| P/E Ratio | ★ N/A | $115.18 |
| Revenue Growth | N/A | ★ 5.42 |
| 52 Week Low | $27.07 | $103.23 |
| 52 Week High | $58.49 | $161.98 |
| Indicator | SRRK | ATR |
|---|---|---|
| Relative Strength Index (RSI) | 39.63 | 63.22 |
| Support Level | $45.46 | $121.60 |
| Resistance Level | $48.23 | $132.42 |
| Average True Range (ATR) | 2.44 | 2.85 |
| MACD | -1.01 | 0.02 |
| Stochastic Oscillator | 6.24 | 64.81 |
Scholar Rock Holding Corp is a biopharmaceutical company focused on improving the lives of children and adults with Spinal Muscular Atrophy and other rare, severe, and debilitating neuromuscular diseases. Its pipeline candidates include apitegromab and a subcutaneous formulation of apitegromab. The clinical-stage pipeline also includes SRK-439, an investigational subcutaneously administered fully human anti-pro/latent myostatin antibody with high inhibitory potency and selectivity toward myostatin, being developed for the treatment of rare neuromuscular diseases. The company also maintains early-stage programs focused on therapies for rare, severe, and debilitating neuromuscular diseases.
Headquartered in Crystal Lake, Illinois, AptarGroup is a leading global supplier of dispensing systems such as aerosol valves, pumps, closures, and elastomer packaging components to the consumer goods and pharmaceutical markets. Its sales are primarily from Europe (49% of sales) and the United States (28%), with China contributing 5% and other countries contributing 17%. It operates three business segments, Pharma, Beauty, and Closures. Pharma generates over two thirds of group profits.